Cite
HARVARD Citation
Choi, S. et al. (2021). An open-label, comparative, single dose, clinical Phase Ⅰ study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults. Vaccine. 39 (19), pp. 2620-2627. [Online].